Boston Scientific Corporation with price, financials, news flow, and insider context in one page.
Boston Scientific Corporation is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where BSX sits inside Healthcare and Medical Devices, and the key financial markers that matter before moving into a fuller research workflow.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
This page is structured for research context, not a trade call. It gives you a clean read on where BSX sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 5.2B | 1.34B | 171M |
| Q4 2025 | 5.29B | 672M | 939M |
| Q3 2025 | 5.07B | 755M | 1.09B |
| Q2 2025 | 5.06B | 797M | 1.1B |
Xbox consoles, Nintendo's new Switch 2 and Valve's Steam Deck are just some of the gadgets seeing price hikes in recent months.
The attacks come as the United States and Iran are supposed to be engaging in a 60-day ceasefire as they attempt to work toward a resolution.
The nomination comes after former ICE director Todd Lyons resigned at the end of May. David Venturella has been serving as the acting head of the agency.
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
Boston Scientific Corporation (BSX) — questions investors ask
What is the current stock price of Boston Scientific Corporation (BSX)?
Boston Scientific Corporation (BSX) is trading at $44.23, up 0.07% in the latest session. The live price and one-year chart on this page update through the trading day.
What is Boston Scientific Corporation's market capitalization?
Boston Scientific Corporation has a market capitalization of about 65.74B, derived from the latest share price and shares outstanding.
When is Boston Scientific Corporation's next earnings date?
Boston Scientific Corporation is next expected to report earnings on Jul 29, 2026. The BSX earnings page tracks the estimate and reporting history.
What is Boston Scientific Corporation's P/E ratio?
Boston Scientific Corporation trades at a forward price-to-earnings ratio of 11.89 — one measure of how the market is pricing its future earnings.
What is BSX's 52-week trading range?
Over the past 52 weeks, BSX has traded between $43.89 and $109.50.
What sector is Boston Scientific Corporation in?
Boston Scientific Corporation operates in the Healthcare sector, within the Medical Devices industry.
What is the analyst price target for BSX?
The mean analyst price target for BSX is $75.00, with an overall analyst view of Buy.
A public stock page should answer the first research questions before asking for a signup.
This BSX page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.